Skip to main content

Global fund to fight AIDS, tuberculosis and malaria

An international conference calls for substantially increased funding to undertake basic research and start to fight the scourge of AIDS in the developing world.

Written byNancy Heneson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00

It's hardly news that the best intentions of governments and the expertise of public health and infectious disease researchers have not succeeded in containing the AIDS epidemic in Africa and other parts of the developing world.

But in April 2001, when UN Secretary General Kofi Annan called for the establishment of a global fund on AIDS and health, hopes rose that the addition of a third critical element — major investment of funds in a coordinated international effort — could promote the integrated goals of controlling HIV and two major related diseases, tuberculosis and malaria.

In October 2001 in Baltimore, Maryland, the Johns Hopkins University Center for AIDS Research hosted a two-day conference that shed some light on whether this hope is warranted. Given that the UN has estimated the cost of preventing and treating AIDS alone in the developing world at 7 to 10 billion dollars annually, and that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays